| Tretinoin | Approved Investigational Nutraceutical | ADAMTS9 | 56999 |
upregulated | Tretinoin results in increased expression of ADAMTS9 mRNA | 3p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ADAMTSL2 | 9719 |
downregulated | Tretinoin results in decreased expression of ADAMTSL2 mRNA | 9q34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADARB1 | 104 |
upregulated | Tretinoin results in increased expression of ADARB1 mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADAT2 | 134637 |
downregulated | Tretinoin results in decreased expression of ADAT2 mRNA | 6q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADCY1 | 107 |
downregulated | Tretinoin results in decreased expression of ADCY1 mRNA | 7p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADCY5 | 111 |
upregulated | Tretinoin results in increased expression of ADCY5 mRNA | 3q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ADCY7 | 113 |
downregulated | Tretinoin results in decreased expression of ADCY7 mRNA | 16q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ADD3 | 120 |
upregulated | Tretinoin results in increased expression of ADD3 mRNA | 10q25.1-q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRA2 | 25960 |
downregulated | Tretinoin results in decreased expression of ADGRA2 mRNA | 8p11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRE1 | 2015 |
upregulated | Tretinoin results in increased expression of ADGRE1 mRNA | 19p13.3-p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRE5 | 976 |
downregulated | Tretinoin results in decreased expression of ADGRE5 mRNA | 19p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRF1 | 266977 |
upregulated | Tretinoin results in increased expression of ADGRF1 mRNA | 6p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRF5 | 221395 |
upregulated | Tretinoin results in increased expression of ADGRF5 mRNA | 6p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRG1 | 9289 |
downregulated | Tretinoin results in decreased expression of ADGRG1 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRG6 | 57211 |
upregulated | Tretinoin results in increased expression of ADGRG6 mRNA | 6q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRL1 | 22859 |
downregulated | Tretinoin results in decreased expression of ADGRL1 mRNA | 19p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ADGRL4 | 64123 |
upregulated | Tretinoin results in increased expression of ADGRL4 mRNA | 1p31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ADH1A | 124 |
upregulated | Tretinoin results in increased expression of ADH1A mRNA | 4q23 | |
| Tretinoin | Approved Investigational Nutraceutical | ADH1C | 126 |
upregulated | Tretinoin results in increased expression of ADH1C mRNA | 4q23 | |
| Tretinoin | Approved Investigational Nutraceutical | ADH5 | 128 |
upregulated | Tretinoin results in increased expression of ADH5 mRNA | 4q23 | |
| Tretinoin | Approved Investigational Nutraceutical | ADI1 | 55256 |
downregulated | Tretinoin results in decreased expression of ADI1 mRNA | 2p25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADIRF | 10974 |
upregulated | Tretinoin results in increased expression of ADIRF mRNA | 10q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADM | 133 |
downregulated | Tretinoin results in decreased expression of ADM mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | ADM | 133 |
upregulated | Tretinoin results in increased expression of ADM mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | ADNP2 | 22850 |
downregulated | Tretinoin results in decreased expression of ADNP2 mRNA | 18q23 | |